Is Clover Health Investments, Corp. (CLOV) a Buy, Sell, or Hold?
NASDAQ : CLOV
Clover Health Investments, Corp.
$4.17 USD
-$0.17 (-3.92%)
- Volume
- 3.54M
- Average Volume
- 7.41M
- Market Capitalization
- $2.16B
- P/E Ratio
- -37.47
- Dividend Yield
- 0.00%
- Price Target
- $5.13
- Year High
- $5.59
- Year Low
- $1.58
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.33
Company Overview
NASDAQ
Andrew Toy
Medical - Healthcare Plans
Healthcare
CLOV
724
US
USD
Liquidity Metrics
0.00
1.33
1.33
0.51
0.00
Sales & Valuation
$1.92B
0.98
6.42
39.62
0.10
Profitability
-$0.17
-$85.55M
-2.58%
-2.58%
-17.08%
-8.16%
P/E Metrics
-37.47
0.48
0.48
Analyst Price Target & Rating
$5.13
$5.50
$4.75
1/5
9 Analysts
-18.63%
Financial Health Scores
2.23
3/9
$111.44M
$697.73M
$358.3M
-$56.94M
Key Metrics (TTM)
$1.99B
0.90
-36.01
1.33
-17.08%
-15.76%
-2.61%
2.52%
-19 days
Company Executives
| Name | Title |
|---|---|
| Kumar Dharmarajan | Chief Medical Officer of Clover Assistant |
| Brady Priest | Chief Executive Officer of Clover Care Services |
| Conrad Wai | Chief Executive Officer of Counterpart Health |
| Jamie L. Reynoso | Chief Executive Officer of Medicare Advantage |
| Karen Soares | Chief Legal Officer, General Counsel, Senior VP & Corporate Secretary |
| Vivek Garipalli | Co-Founder & Executive Chairman |
| Wendy Richey | Chief Compliance Officer |
| Joseph Frank Oldakowski | VP of Finance, Controller & Principal Accounting Officer |
| Clay Thornton | Interim Chief Financial Officer |
| Rachel Fish | Chief People Officer |
| Andrew Toy | Co-Founder, Chief Executive Officer & Director |
Poll Results
No votes yet today — be the first to share your view!
About Clover Health Investments, Corp. (NASDAQ:CLOV) Stock
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee. ...
Clover Health's CEO Just Sold 62,711 Shares for Tax Withholding. The Bigger News Comes Next Week.
2026-07-31 08:21:01
The disposition involved 62,711 shares at a weighted average price of $4.67 per share, totaling ~$292,860 in transaction value. The transaction represented 0.65% of the executive's direct equity holdings in the healthcare firm.
Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference
2026-07-22 16:05:00
WILMINGTON, Del., July 22, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial Officer, Clay Thornton, will present at the 2026 Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, at 8:30 a.m.
Clover Health says employee accounts accessed in cyber incident
2026-07-17 16:49:19
Clover Health Investments said in a regulatory filing on Friday that it detected unusual login activity on some of its information systems on July 4 and later found a hacker had gained access to three employee accounts through social engineering.
Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026
2026-07-09 16:05:00
WILMINGTON, Del., July 09, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Wednesday, August 5, 2026.
2026-07-07 08:30:00
SAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or “Clover Health”), and a leading AI-powered physician enablement platform, today released findings within the whitepaper “Clinical Excellence in Continuity of Care: A Real-World Analysis of Counterpart Assistant's Role in Post-Hospitalization Follow-up.” The whitepaper examines the relationship between CA use by primary care physicians (“PCPs”) and performance on high-risk care transition outcomes, including two HEDIS®1 quality measures within Clover Health's Medicare Advantage population: Transitions of Care (“TRC”) and Follow-Up After Emergency Department Visit for People with Multiple High-Risk Chronic Conditions (“FMC”).
Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.
2026-07-06 20:32:01
CEO Andrew Toy sold 313,476 shares of Common Stock for a transaction value of ~$1.67 million as of July 1, 2026. This transaction represented 3.16% of Toy's direct holdings, reducing direct ownership to 9,609,825 shares.
A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.
2026-06-27 13:13:01
Director Carladenise Edwards sold 67,160 shares for a transaction value of approximately ~$230,000 on May 18, 2026, at a weighted average price of around $3.42 per share. This sale represented 19% of her direct holdings at the time, reducing direct ownership from 352,592 to 285,432 shares.
Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating
2026-06-11 07:32:42
Clover Health Investments Corp. (NASDAQ:CLOV) shares are extending yesterday's 18.9% surge Thursday, after a court-ordered Medicare Star Rating upgrade jumped its PPO plan from 3.5 to 4.5 Stars.
Frequently Asked Questions
-
What is the current Clover Health Investments, Corp. (CLOV) stock price?
-
Clover Health Investments, Corp.(NASDAQ:CLOV) stock price is $4.17 in the last trading session. During the trading session, CLOV stock reached the peak price of $5.59 while $1.58 was the lowest point it dropped to. The percentage change in CLOV stock occurred in the recent session was --3.92% while the dollar amount for the price change in CLOV stock was -$0.17.
-
CLOV's industry and sector of operation?
-
The NASDAQ listed CLOV is part of Medical - Healthcare Plans industry that operates in the broader Healthcare sector.
-
Who are the executives of CLOV?
-
Kumar Dharmarajan | Chief Medical Officer of Clover Assistant
Brady Priest | Chief Executive Officer of Clover Care Services
Conrad Wai | Chief Executive Officer of Counterpart Health
Jamie L. Reynoso | Chief Executive Officer of Medicare Advantage
Karen Soares | Chief Legal Officer, General Counsel, Senior VP & Corporate Secretary -
How many employees does CLOV have?
-
Number of CLOV employees currently stands at 724. CLOV operates from 1209 Orange Street, Wilmington, DE 19801, US.
-
Link for CLOV official website?
-
Official Website of CLOV is: https://www.cloverhealth.com
-
How do I contact CLOV?
-
CLOV could be contacted at phone #201 432 2133 and can also be accessed through its website. CLOV operates from 1209 Orange Street, Wilmington, DE 19801, US.
-
How many shares of CLOV are traded daily?
-
The average number of CLOV shares traded daily for last 3 months was 7.41M.
-
What is the market cap of CLOV currently?
-
The market value of CLOV currently stands at $2.16B with its latest stock price at $4.17